Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Weight Loss

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription

The Independent UK

Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now

Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.

International Business Times UK

The ‘dangerous’ threat of fake weight loss injections

IN FULL

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Scientists Discover Ozempic’s Healthier Rival With No Nausea And No Side Effects

"Like starting the race halfway through.”

Bored Panda

‘Life-threatening’: Thousands of bogus online pharmacies selling fake Ozempic jabs

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent medications could be fatal

The Independent UK

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

The US president had put pressure on the pharmaceutical industry to make drugs cheaper for Americans

The Guardian - UK

Ozempic didn’t work for me. I was furious – and ashamed

Everyone taking the ‘skinny shot’ was losing weight, but my scales didn’t change. My inner dialogue became toxic

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro by up to 170%

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Euronews

'Ferrand-Prévot’s weight loss for the Tour puts pressure on all of us,' says Marlen Reusser

Doctor and competitor Marlen Reusser says Ferrand-Prévot’s weight loss sets a worrying standard for the peloton

Cycling Weekly

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss.

Benzinga

The targeted programme found to improve IVF outcomes

Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or through IVF

The Independent UK

Altimmune Q2 FY2025 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.

Benzinga

Weight loss support before IVF could boost pregnancy chances – and reduce the need for treatment

Around one in five women of childbearing age are living with [obesity], defined by the World Health Organization as having a body mass index (BMI) over 30 kg/m². Compared with women in the healthy BMI range (18.5–24.9 kg/m²), those living with obesity are three times more likely to experience fertility…

The Conversation

The serious eye conditions linked to weight loss drugs

IN FULL

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

AAP

Patient's heartbreaking final words before death

A woman uttered five striking words to her family from her hospital bed before she died of complications arising from her pursuit of a healthier life.

MarketBeat

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

MarketBeat

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?

Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.

Euronews

Portugal tightens rules on weight loss drug prescriptions to prevent misuse

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Tammy Slaton defends decision to drink soda ‘in moderation’ amid weight loss journey

IN FULL

The Guardian - UK

Daily pill helps patients lose 12% of body weight in early trial

Results of study suggest orforglipron could be a simpler, cheaper alternative to injections

The Conversation

Weight loss jabs and cancer risk: here’s what you need to know about the research so far

So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have started to emerge about maintaining ready supplies. But with popularity comes scrutiny, and rising demand isn’t the only potential problem with weight loss jabs.

International Business Times UK

'Ozempic Penis'? Male Users Claim Genital Growth After Weight Loss Jab Goes Viral

Men using Ozempic report genital growth after weight loss. Doctors say it's fat loss, not drug-related changes, sparking viral debate online.

Barchart

This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst

Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.

The Independent UK

Shares fall after weight loss pill disappoints in trial

IN FULL

Euronews

Eli Lilly will seek approval for experimental weight loss pill after promising study

Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.

1 … 14 15 16 17

People

Pauline FerrandPrévot

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the University of Oxford

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.